Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction.

Schroder J, Mygind ND, Frestad D, Michelsen M, Suhrs HE, Bove KB, Gustafsson I, Kastrup J, Prescott E.

Int J Cardiol Heart Vasc. 2019 May 30;24:100370. doi: 10.1016/j.ijcha.2019.100370. eCollection 2019 Sep.

2.

Peripheral Endothelial Function and Coronary Flow Velocity Reserve Are Not Associated in Women with Angina and No Obstructive Coronary Artery Disease: The iPOWER Study.

Flintholm Raft K, Frestad D, Michelsen MM, Suhrs HE, Rask AB, Nilsson M, Hermann TS, Prescott E.

J Vasc Res. 2017;54(5):309-319. doi: 10.1159/000479374. Epub 2017 Sep 23.

PMID:
28942444
3.

Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.

Michelsen MM, Mygind ND, Pena A, Aziz A, Frestad D, Høst N, Prescott E; Steering Committee of the iPOWER Study.

JACC Cardiovasc Imaging. 2016 Apr;9(4):411-7. doi: 10.1016/j.jcmg.2016.02.005.

4.

Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.

Mygind ND, Michelsen MM, Pena A, Frestad D, Dose N, Aziz A, Faber R, Høst N, Gustafsson I, Hansen PR, Hansen HS, Bairey Merz CN, Kastrup J, Prescott E.

J Am Heart Assoc. 2016 Mar 15;5(3):e003064. doi: 10.1161/JAHA.115.003064.

5.

Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.

Michelsen MM, Pena A, Mygind ND, Bech J, Gustafsson I, Kastrup J, Hansen HS, Høst N, Hansen PR, Prescott E.

Echocardiography. 2018 Feb;35(2):196-203. doi: 10.1111/echo.13767. Epub 2017 Dec 8.

PMID:
29222822
6.

Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.

Mygind ND, Michelsen MM, Pena A, Qayyum AA, Frestad D, Christensen TE, Ghotbi AA, Dose N, Faber R, Vejlstrup N, Hasbak P, Kjaer A, Prescott E, Kastrup J; steering committee of the iPower study.

J Cardiovasc Magn Reson. 2016 Nov 4;18(1):76.

7.

Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER study.

Michelsen MM, Mygind ND, Pena A, Olsen RH, Christensen TE, Ghotbi AA, Hasbak P, Kjaer A, Gustafsson I, Hansen PR, Hansen HS, Høst N, Kastrup J, Prescott E.

Int J Cardiol. 2017 Feb 1;228:435-443. doi: 10.1016/j.ijcard.2016.11.004. Epub 2016 Nov 7.

PMID:
27870973
8.

Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease.

Schroder J, Zethner-Moller R, Bové KB, Mygind ND, Hasbak P, Michelsen MM, Gustafsson I, Kastrup J, Prescott E.

Atherosclerosis. 2018 Aug;275:319-327. doi: 10.1016/j.atherosclerosis.2018.06.864. Epub 2018 Jun 19.

PMID:
29981522
9.

Coronary microvascular dysfunction is not associated with a history of reproductive risk factors in women with angina pectoris-An iPOWER substudy.

Suhrs HE, Kristensen AM, Rask AB, Michelsen MM, Frestad D, Mygind ND, Bové K, Prescott E.

Maturitas. 2018 Jan;107:110-115. doi: 10.1016/j.maturitas.2017.07.004. Epub 2017 Aug 12.

PMID:
28807722
10.

Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.

Pena A, Michelsen MM, Mygind ND, Gustafsson I, Høst N, Bech J, Kastrup J, Hansen HS, Hansen PR, Prescott E.

Echocardiography. 2019 Jun;36(6):1110-1117. doi: 10.1111/echo.14356. Epub 2019 Apr 22.

PMID:
31012159
11.

Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition.

Kakuta K, Dohi K, Sato Y, Yamanaka T, Kawamura M, Ogura T, Nakamori S, Fujimoto N, Fujii E, Yamada N, Ito M.

J Am Soc Echocardiogr. 2016 Feb;29(2):173-80. doi: 10.1016/j.echo.2015.09.001. Epub 2015 Oct 9.

PMID:
26443046
12.

Ventricular repolarization alterations in women with angina pectoris and suspected coronary microvascular dysfunction.

Dose N, Michelsen MM, Mygind ND, Pena A, Ellervik C, Hansen PR, Kanters JK, Prescott E; Steering Committee of the iPOWER study, Kastrup J, Gustafsson I, Hansen HS.

J Electrocardiol. 2018 Jan - Feb;51(1):15-20. doi: 10.1016/j.jelectrocard.2017.08.017. Epub 2017 Aug 17.

PMID:
28939174
13.

Coronary Flow Velocity Reserve Assessed by Transthoracic Doppler: The iPOWER Study: Factors Influencing Feasibility and Quality.

Michelsen MM, Pena A, Mygind ND, Frestad D, Gustafsson I, Hansen HS, Kastrup J, Bech J, Høst N, Prescott E.

J Am Soc Echocardiogr. 2016 Jul;29(7):709-16. doi: 10.1016/j.echo.2016.02.011. Epub 2016 Mar 31.

PMID:
27038514
14.

Prognostic meaning of coronary microvascular disease in type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study.

Cortigiani L, Rigo F, Gherardi S, Galderisi M, Bovenzi F, Sicari R.

J Am Soc Echocardiogr. 2014 Jul;27(7):742-8. doi: 10.1016/j.echo.2014.02.010. Epub 2014 Mar 26.

PMID:
24679741
15.

Noninvasive coronary flow velocity reserve measurement in the posterior descending coronary artery for detecting coronary stenosis in the right coronary artery using contrast-enhanced transthoracic Doppler echocardiography.

Watanabe H, Hozumi T, Hirata K, Otsuka R, Tokai K, Muro T, Shimada K, Yoshiyama M, Takeuchi K, Yoshikawa J.

Echocardiography. 2004 Apr;21(3):225-33.

PMID:
15053784
16.

Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction.

Suhrs HE, Raft KF, Bové K, Madsbad S, Holst JJ, Zander M, Prescott E.

Int J Cardiol. 2019 May 15;283:28-34. doi: 10.1016/j.ijcard.2018.12.005. Epub 2019 Jan 2.

PMID:
30773266
17.

Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction.

Wöhrle J, Nusser T, Merkle N, Kestler HA, Grebe OC, Marx N, Höher M, Kochs M, Hombach V.

J Cardiovasc Magn Reson. 2006;8(6):781-7.

PMID:
17060099
18.

Acceleration time of systolic coronary flow velocity to diagnose coronary stenosis in patients with microvascular dysfunction.

Takemoto K, Hirata K, Wada N, Shiono Y, Komukai K, Tanimoto T, Ino Y, Kitabata H, Takarada S, Nakamura N, Kubo T, Tanaka A, Imanishi T, Akasaka T.

J Am Soc Echocardiogr. 2014 Feb;27(2):200-7. doi: 10.1016/j.echo.2013.10.013. Epub 2013 Dec 15.

PMID:
24345631
19.

Measurement of coronary flow velocity reserve in the posterior descending coronary artery by contrast-enhanced transthoracic Doppler echocardiography.

Takeuchi M, Ogawa K, Wake R, Takise H, Miyazaki C, Otani S, Sakamoto K, Yoshikawa J.

J Am Soc Echocardiogr. 2004 Jan;17(1):21-7.

PMID:
14712183
20.

Myocardial first pass perfusion assessed by cardiac magnetic resonance and coronary microvascular dysfunction in women with angina and no obstructive coronary artery disease.

Mygind ND, Pena A, Mide Michelsen M, Ali Qayyum A, Frestad D, Emil Christensen T, Ali Ghotbi A, Hasbak P, Kjaer A, Vejlstrup N, Gustafsson I, Riis Hansen P, Steen Hansen H, Prescott E, Kastrup J.

Scand J Clin Lab Invest. 2019 Jul;79(4):238-246. doi: 10.1080/00365513.2019.1587670. Epub 2019 Mar 20.

PMID:
30889989

Supplemental Content

Support Center